Viewing StudyNCT01500824



Ignite Creation Date: 2024-05-06 @ 12:09 AM
Last Modification Date: 2024-10-26 @ 10:45 AM
Study NCT ID: NCT01500824
Status: WITHDRAWN
Last Update Posted: 2013-02-25
First Post: 2011-12-22

Brief Title: A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase ALK Positive Advanced Non-Small Cell Lung Cancer
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Non-Small Cell Lung Cancer
Keywords:
Name View
Asian View
Crizotinib View
ALK View
NSCLC View
Non-Small Cell Lung Cancer View